Hypertension in periand postmenopausal women: mechanisms, management, observation
Authors:
- E. A. PolyakovaE. A. Polyakova
- A. O. KonradiAKA. O. Konradi
- E. I. BaranovaEBE. I. Baranova
- A. S. GalyavichAGA. S. Galyavich
- Y. V. ZhernakovaYZY. V. Zhernakova
- T. N. NovikovaTNT. N. Novikova
- N. I. TapilskayaNTN. I. Tapilskaya
- O. N. TkachevaOTO. N. Tkacheva
- O. D. OstroumovaOOO. D. Ostroumova
- V. V. SkibitskyVSV. V. Skibitsky
- G. A. ChumakovaGCG. A. Chumakova
Open Access
- 12 December 2023
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (1) , 5729
Abstract
An important role in the development and evolution of hypertension in females is applied to sex hormones. Estrogen deficiency and hyperandrogenism, characteristic of periand postmenopause, are links in the pathogenesis of hypertension in this period of a woman's life and are accompanied by an increase in sympathetic nervous system activity, renin-angiotensin-aldosterone system activation, salt sensitivity, abdominal obesity and metabolic syndrome, left ventricle hypertrophy, left atrial dilatation with a high risk of atrial fibrillation, stroke and heart failure development. The paper discusses antihypertensive therapy during periand postmenopause, effectiveness and tolerability of different drug classes. Special attention is paid to the mechanism of action of selective I1-imidazoline receptor agonist moxonidine, which in women during this period both effectively reduces high blood pressure and has a beneficial metabolic effect, what is documents in studies of monotherapy, combined antihypertensive therapy with major classes and in combination with menopausal hormone therapy. The paper presents the joint expert opinion concerning above mentioned issues.Keywords
This publication has 50 references indexed in Scilit:
- Cardiovascular health and the menopause, metabolic healthBest Practice & Research Clinical Endocrinology & Metabolism, 2023
- The Role of Estrogen in Insulin ResistanceThe American Journal of Pathology, 2021
- Comparing an adiposopathy approach with four popular classifications schemes to categorize the metabolic profile of postmenopausal womenJournal of Physiology and Biochemistry, 2020
- Sex-Specific Mechanisms in Inflammation and HypertensionCurrent Hypertension Reports, 2019
- Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study)Nutrition, Metabolism and Cardiovascular Diseases, 2018
- Gender Differences in Epidemiology, Pathophysiology, and Treatment of HypertensionCurrent Atherosclerosis Reports, 2018
- Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndromeAGE, 2013
- Rationale, Design, and Findings from the Wisconsin Sleep Cohort Study: Toward Understanding the Total Societal Burden of Sleep-Disordered BreathingSleep Medicine Clinics, 2009
- Dietary Intakes of Nutrients Thought to Modify Cardiovascular Risk from Three Groups of American Indians: The Strong Heart Dietary Study, Phase IIJournal of the American Dietetic Association, 2005
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002